Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016 (2016), Article ID 4710979, 6 pages
http://dx.doi.org/10.1155/2016/4710979
Case Report

Giant Condyloma Acuminata in Indonesian Females with SLE under Immunosuppressant and Steroid Therapy

1Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia
2Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Received 9 June 2016; Revised 27 September 2016; Accepted 4 October 2016

Academic Editor: Anne E. Tebo

Copyright © 2016 Andhika Rachman and Nabila Hasan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. M. Faco, C. Leone, L. M. A. Campos, M. V. Febrônio, H. H. S. Marques, and C. A. Silva, “Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 7, pp. 993–1002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. N. I. Vet, M. A. de Boer, B. E. W. M. van den Akker et al., “Prevalence of human papillomavirus in Indonesia: a population-based study in three regions,” British Journal of Cancer, vol. 99, no. 1, pp. 214–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kreuter, A. Potthoff, N. H. Brockmeyer et al., “Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany,” British Journal of Dermatology, vol. 162, no. 6, pp. 1269–1277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Ganguly, S. Waller, C. J. Stasik, B. S. Skikne, and S. Ganguly, “Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection,” Transplant Infectious Disease, vol. 10, no. 1, pp. 56–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Daneshpouy, G. Socie, C. Clavel et al., “Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipient,” Transplantation, vol. 71, no. 1, pp. 167–169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L.-S. Tam, P. K. S. Chan, S. C. Ho et al., “Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study,” Arthritis Care & Research, vol. 63, no. 2, pp. 269–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. I. U. Santana, A. D. N. Gomes, L. D. Lyrio, M. F. Rios Grassi, and M. B. Santiago, “Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review,” Clinical Rheumatology, vol. 30, no. 5, pp. 665–672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Nath, C. Mant, J. Luxton et al., “High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients,” Arthritis Care and Research, vol. 57, no. 4, pp. 619–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Lube, N. E. Aikawa, M. Tacla et al., “Condyloma acuminatum by human papilloma virus infection in childhood-systemic lupus erythematosus patients,” Acta Reumatológica Portuguesa, vol. 39, no. 2, pp. 182–187, 2014. View at Google Scholar
  10. L. Costapinto, M. F. R. Grassi, K. Serravalle, A. C. V. Travessa, V. N. O. Olavarria, and M. B. Santiago, “Giant disseminated condylomatosis in SLE,” Lupus, vol. 21, no. 3, pp. 332–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Thornsberry and J. C. English III, “Evidence-based treatment and prevention of external genital warts in female pediatric and adolescent patients,” Journal of Pediatric and Adolescent Gynecology, vol. 25, no. 2, pp. 150–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hariri, E. R. Unger, M. Sternberg et al., “Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006,” The Journal of Infectious Diseases, vol. 204, no. 4, pp. 566–573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. U. Martínez-Martínez, L. Baranda-Cándido, and C. Abud-Mendoza, “Cutaneous papillomavirus infection in patients with rheumatoid arthritis or systemic lupus erythematosus. A case-control study,” Lupus, vol. 22, no. 9, pp. 948–952, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Amador-Molina, J. F. Hernández-Valencia, E. Lamoyi, A. Contreras-Paredes, and M. Lizano, “Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response,” Viruses, vol. 5, no. 11, pp. 2624–2642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. V. M. Renoux, B. Bisig, I. Langers et al., “Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion,” European Journal of Immunology, vol. 41, no. 11, pp. 3240–3252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Henriques, L. Teixeira, L. Inês et al., “NK cells dysfunction in systemic lupus erythematosus: relation to disease activity,” Clinical Rheumatology, vol. 32, no. 6, pp. 805–813, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Mendoza-Pinto, M. Garcia-Carrasco, V. Vallejo-Ruiz et al., “The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus,” Clinics, vol. 68, no. 12, pp. 1475–1480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Abud-Mendoza, E. Cuevas-Orta, E. N. Santillán-Guerrero et al., “Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV),” Archives of Dermatological Research, vol. 305, no. 2, pp. 117–123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. E. M. Klumb, A. C. Pinto, G. R. Jesus et al., “Are women with lupus at higher risk of HPV infection?” Lupus, vol. 19, no. 13, pp. 1485–1491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. G. Katzung, Basic and Clinical Pharmacology, McGraw-Hill, New York, NY, USA, 10th edition, 2006.
  21. K. P. Maniar, B. M. Ronnett, R. Vang, and A. Yemelyanova, “Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients,” American Journal of Surgical Pathology, vol. 37, no. 1, pp. 53–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C. K. Fairley, J. S. Hocking, L. C. Gurrin, M. Y. Chen, B. Donovan, and C. S. Bradshaw, “Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women,” Sexually Transmitted Infections, vol. 85, no. 7, pp. 499–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. C. Mok, L. Y. Ho, L. S. Fong, and C. H. To, “Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study,” Annals of the Rheumatic Diseases, vol. 72, no. 5, pp. 659–664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Aubin, M. Martin, E. Puzenat et al., “Genital human Papillomavirus infection in patients with autoimmune inflammatory diseases,” Joint Bone Spine, vol. 78, no. 5, pp. 460–465, 2011. View at Publisher · View at Google Scholar · View at Scopus